Day One Biopharmaceuticals (DAWN) Financial Statements
Price: $7.12
Market Cap: $721.65M
Avg Volume: 1.21M
Market Cap: $721.65M
Avg Volume: 1.21M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Day One Biopharmaceuticals.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | $131.16M | $- | $- | $- | $- | $- |
| Cost of Revenue | $5.28M | $383.00K | $531.00K | $199.00K | $155.00K | $- |
| Gross Profit | $125.88M | $-383.00K | $-531.00K | $-199.00K | $-155.00K | $- |
| Gross Profit Ratio | 95.98% | - | - | - | - | 0.00% |
| Research and Development Expenses | $227.70M | $130.52M | $85.62M | $43.58M | $9.10M | $13.90M |
| General and Administrative Expenses | $- | $75.54M | $61.29M | $29.16M | $4.68M | $1.01M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $115.45M | $75.54M | $61.29M | $29.16M | $4.68M | $1.01M |
| Other Expenses | $- | $1 | $-18.00K | $-15.00K | $-31.00K | $-2.00K |
| Operating Expenses | $343.15M | $206.06M | $146.91M | $72.74M | $13.78M | $14.90M |
| Cost and Expenses | $348.43M | $206.06M | $146.91M | $72.74M | $13.78M | $14.90M |
| Interest Income | $- | $17.19M | $4.75M | $4.00K | $30 | $2.08K |
| Interest Expense | $- | $- | $4.75M | $4.00K | $30.00K | $2.08M |
| Depreciation and Amortization | $- | $383.00K | $531.00K | $199.00K | $155.00K | $14.90M |
| EBITDA | $-217.27M | $-206.06M | $-141.65M | $-72.56M | $-43.66M | $-2.00K |
| EBITDA Ratio | -165.65% | - | - | - | - | - |
| Operating Income | $-217.27M | $-206.06M | $-146.91M | $-72.74M | $-13.78M | $-14.90M |
| Operating Income Ratio | -165.65% | - | - | - | - | - |
| Total Other Income Expenses Net | $128.92M | $17.15M | $4.73M | $-11.00K | $-30.06M | $-2.08M |
| Income Before Tax | $-88.35M | $-188.92M | $-142.18M | $-72.75M | $-43.84M | $-16.98M |
| Income Before Tax Ratio | -67.36% | - | - | - | - | - |
| Income Tax Expense | $-7.14M | $- | $-10.01M | $-2.31M | $-3.34M | $-2.27M |
| Net Income | $-95.50M | $-188.92M | $-132.18M | $-70.44M | $-40.51M | $-14.71M |
| Net Income Ratio | -72.81% | - | - | - | - | - |
| EPS | $-1.02 | $-2.37 | $-2.02 | $-1.14 | $-0.65 | $-0.24 |
| EPS Diluted | $-1.02 | $-2.37 | $-2.02 | $-1.14 | $-0.65 | $-0.24 |
| Weighted Average Shares Outstanding | 93.62M | 79.77M | 65.47M | 61.95M | 61.93M | 61.93M |
| Weighted Average Shares Outstanding Diluted | 93.62M | 79.77M | 65.47M | 61.95M | 61.93M | 61.93M |
| SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $124.97M | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M |
| Short Term Investments | $406.75M | $135.56M | $257.01M | $- | $- | $- |
| Cash and Short Term Investments | $531.72M | $366.35M | $342.27M | $284.31M | $43.73M | $27.33M |
| Net Receivables | $13.88M | $- | $- | $- | $- | $- |
| Inventory | $3.32M | $- | $- | $- | $- | $- |
| Other Current Assets | $13.41M | $8.93M | $5.61M | $5.06M | $1.34M | $7.00K |
| Total Current Assets | $562.33M | $375.27M | $347.87M | $289.37M | $45.07M | $27.34M |
| Property Plant Equipment Net | $4.71M | $560.00K | $719.00K | $284.00K | $483.00K | $- |
| Goodwill | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $15.63M | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $15.63M | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $121.00K | $214.00K | $469.00K | $169.00K | $107.00K | $- |
| Total Non-Current Assets | $20.46M | $774.00K | $1.19M | $453.00K | $590.00K | $- |
| Other Assets | $- | $- | $- | $-0 | $- | $- |
| Total Assets | $582.79M | $376.05M | $349.06M | $289.82M | $45.66M | $27.34M |
| Account Payables | $3.26M | $2.58M | $260.00K | $1.74M | $202.00K | $69.00K |
| Short Term Debt | $10.00K | $408.00K | $810.00K | $408.00K | $198.00K | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $1.55M | $- | $- | $6.61M | $1.57M | $- |
| Other Current Liabilities | $68.62M | $26.52M | $15.54M | $6.50M | $1.60M | $1.95M |
| Total Current Liabilities | $73.45M | $29.51M | $16.61M | $8.66M | $2.00M | $2.02M |
| Long Term Debt | $2.59M | $- | $408.00K | $16.00K | $204.00K | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $3.99M | $- | $- | $- | $91.96M | $30.50M |
| Total Non-Current Liabilities | $6.59M | $- | $408.00K | $16.00K | $92.17M | $30.50M |
| Other Liabilities | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $80.04M | $29.51M | $17.02M | $8.67M | $94.16M | $32.52M |
| Preferred Stock | $- | $- | $- | $- | $5.70M | $5.49M |
| Common Stock | $10.00K | $9.00K | $7.00K | $6.00K | $2.00M | $2.00M |
| Retained Earnings | $-554.08M | $-458.58M | $-269.67M | $-127.49M | $-56.84M | $-12.78M |
| Accumulated Other Comprehensive Income Loss | $84.00K | $9.00K | $-71.00K | $0 | $637 | $111 |
| Other Total Stockholders Equity | $1.06B | $805.11M | $601.77M | $408.63M | $92.60M | $-5.38M |
| Total Stockholders Equity | $502.75M | $346.54M | $-269.67M | $-127.49M | $-54.20M | $-10.67M |
| Total Equity | $502.75M | $346.54M | $-269.67M | $162.33M | $-48.50M | $-5.19M |
| Total Liabilities and Stockholders Equity | $582.79M | $376.05M | $-252.65M | $-118.81M | $45.66M | $27.34M |
| Minority Interest | $- | $- | $- | $289.82M | $5.70M | $5.49M |
| Total Liabilities and Total Equity | $582.79M | $376.05M | $-252.65M | $-118.81M | $45.66M | $27.34M |
| Total Investments | $406.75M | $135.56M | $257.01M | $- | $- | $- |
| Total Debt | $2.60M | $408.00K | $813.00K | $220.00K | $402.00K | $- |
| Net Debt | $-122.37M | $-230.38M | $-84.45M | $-284.09M | $-43.33M | $-27.33M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-95.50M | $-188.92M | $-142.18M | $-72.75M | $-43.84M | $-16.98M |
| Depreciation and Amortization | $1.56M | $383.00K | $531.00K | $199.00K | $155.00K | $- |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $48.26M | $39.34M | $27.24M | $13.32M | $526.00K | $111.00K |
| Change in Working Capital | $- | $9.42M | $6.56M | $2.69M | $-357.00K | $444.00K |
| Accounts Receivables | $-13.88M | $- | $- | $- | $- | $- |
| Inventory | $-3.24M | $- | $- | $- | $- | $- |
| Accounts Payables | $686.00K | $2.32M | $-1.48M | $1.54M | $132.00K | $14.00K |
| Other Working Capital | $- | $7.10M | $8.05M | $1.15M | $-489.00K | $430.00K |
| Other Non Cash Items | $-32.44M | $-7.08M | $-2.03M | $8.00M | $30.03M | $11.91M |
| Net Cash Provided by Operating Activities | $-78.11M | $-146.85M | $-109.87M | $-48.54M | $-13.49M | $-4.51M |
| Investments in Property Plant and Equipment | $-2.17M | $-224.00K | $-26.00K | $-8.00M | $-92.00K | $- |
| Acquisitions Net | $- | $- | $255.05K | $- | $- | $- |
| Purchases of Investments | $-658.62M | $-443.84M | $-394.21M | $- | $- | $- |
| Sales Maturities of Investments | $393.89M | $575.44M | $139.16M | $- | $- | $- |
| Other Investing Activities | $35.90M | $-3.00M | $-255.05K | $-8.00M | $- | $- |
| Net Cash Used for Investing Activities | $-230.99M | $128.38M | $-255.07M | $-8.00M | $-92.00K | $- |
| Debt Repayment | $- | $- | $- | $- | $- | $1.00M |
| Common Stock Issued | $178.18M | $161.41M | $161.61M | $167.04M | $29.98M | $29.91M |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $25.11M | $5.18M | $4.29M | $130.07M | $29.98M | $29.91M |
| Net Cash Used Provided by Financing Activities | $203.29M | $164.00M | $165.90M | $297.12M | $29.98M | $30.91M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-105.82M | $145.52M | $-199.05M | $240.58M | $16.40M | $26.39M |
| Cash at End of Period | $124.97M | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M |
| Cash at Beginning of Period | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M | $942.00K |
| Operating Cash Flow | $-78.11M | $-146.85M | $-109.87M | $-48.54M | $-13.49M | $-4.51M |
| Capital Expenditure | $-2.17M | $-3.22M | $-26.00K | $-8.00M | $-92.00K | $- |
| Free Cash Flow | $-80.28M | $-150.08M | $-109.90M | $-56.54M | $-13.58M | $-4.51M |